| |
|
|
|
|
|
Amylase
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
This reagent is intended for the quantitative determination of a‑Amylase activity in serum.
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
The determination of amylase activity in serum, plasma and urine is most commonly performed for the diagnosis of acute pancreatitis. In acute pancreatitis, amylase levels are elevated for longer periods of time in urine than in serum. Therefore, determining the ratio of the amylase and creatinine clearances is important in following the course of the pancreatitis.
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
Amylase was first measured quantitatively by an iodometric method introduced by Wohlegemuth in 1908.1 Somogyi introduced a procedure in 1938 that standardized the amounts of starch and iodine.2 His work became the basis for the widely used Amyloclastic and Saccharogenic methods introduced in 19563 and 19604 respectively. Disadvantages of these methods include long incubation times, endogenous glucose interference, and unstable reaction colors resulting in poor reproducibility and reliability.
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
High-Conversion Efficiency Gluco-Amylase
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
Midrange-Thermo-Stable Amylase
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
A Phadebas® tablet consists of homogeneously interlinked starch polymers, taking the form of globular microspheres of defined size. These Bio-Degradable Starch Microspheres (DSM) are insoluble in water.
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
Thermo-Stable α-Amylase
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
α-amylase
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
For the quantitative determination of α -amylase activity in serum, plasma or urine on TC Matrix analyzers.
|
Company:
Date:
March 03, 2009
|
|
|
|
|
|